Related Experiment Videos
A novel SMAD4 gene mutation in seminoma germ cell tumors
M Bouras1, E Tabone, J Bertholon
1Institut National de la Santé et de la Recherche Médicale U407, Faculté de Médecine Lyon-Sud, Oullins, France.
Abstract:
Transforming growth factor (TGF)-beta is known as an antiproliferative factor in the majority of mammalian cells, including stem germ cells. Lack of TGF-beta-induced growth inhibition has been associated with disruptions of TGF-beta receptors and SMADs. In the present study, we performed a mutational analysis of the TGF-beta signaling system, including TGF-beta receptor type I and type II and SMADs (SMAD1-SMAD7), in 20 seminoma germ cell tumors. Using reverse transcription-PCR, single-strand conformational polymorphism, and sequencing analysis, the COOH-terminal domain of SMAD4 was found to be mutated: a single thymine was inserted between nt 1521 and 1522 in 2 of 20 tumors analyzed. This addition of a thymine creates a frameshift and a new stop signal at codon 492, which leads to premature termination of the encoded protein. Such a mutation potentially abrogates signaling from TGF-beta as well as the other TGF-beta family members, including activin and bone morphogenetic protein, which all use the SMAD pathway. Immunohistological analysis confirmed the loss of expression of SMAD4 protein in the seminoma tissues with the insertional mutation. To our knowledge, this is the first description of a novel SMAD4 insertional mutation in seminoma testicular germ cell tumors. This mutational inactivation of SMAD4/COOH-terminal domain may cause TGF-beta unresponsiveness. It could thus provide a basis for understanding the potential role of the TGF-beta system in germ cell tumorigenesis.
Insights
A novel SMAD4 gene mutation was identified in seminoma testicular germ cell tumors, potentially causing unresponsiveness to TGF-beta signaling and contributing to tumor development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Transforming growth factor (TGF)-beta normally inhibits proliferation in mammalian cells, including germ cells.
- Disruptions in TGF-beta receptors or SMAD proteins are linked to a loss of this growth inhibition.
- Seminoma, a type of testicular germ cell tumor, warrants investigation into its underlying molecular mechanisms.
Purpose of the Study:
- To investigate mutations within the TGF-beta signaling pathway, specifically focusing on TGF-beta receptors and SMAD proteins (SMAD1-SMAD7).
- To analyze these components in a cohort of seminoma germ cell tumors.
- To identify potential genetic alterations contributing to seminoma development.
Main Methods:
- Mutational analysis of TGF-beta signaling components in 20 seminoma samples.
- Utilized reverse transcription-PCR, single-strand conformational polymorphism, and sequencing.
- Immunohistological analysis to assess protein expression.
Main Results:
- A novel insertional mutation in the COOH-terminal domain of SMAD4 was discovered in 2 out of 20 seminoma tumors.
- This thymine insertion resulted in a frameshift and premature protein termination.
- Immunohistochemistry confirmed the absence of SMAD4 protein expression in affected tumor tissues.
Conclusions:
- The identified SMAD4 mutation may lead to TGF-beta pathway inactivation and unresponsiveness.
- This molecular defect could play a role in the pathogenesis of seminoma.
- This finding represents the first description of such a SMAD4 mutation in testicular germ cell tumors.